Search research articles
Contact Us
Filters
Showing results (531-540 of 542) with videos related to
Page
of 55
Sort By:
Antimicrobial Agents and Chemotherapy
|
November 27, 2013
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method
M A Pfaller, A Espinel-Ingroff, B Bustamante, et al.
Diagnostic Microbiology and Infectious Disease
|
May 23, 1998
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species
M A Pfaller, S A Messer, A Houston, et al.
Journal of Clinical Microbiology
|
August 21, 2009
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods
M A Pfaller, D J Diekema, M A Ghannoum, et al.
Journal of Clinical Microbiology
|
January 1, 1997
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
A Espinel-Ingroff, M Bartlett, R Bowden, et al.
Journal of Clinical Microbiology
|
March 31, 2012
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution
M A Pfaller, A Espinel-Ingroff, E Canton, et al.
Antimicrobial Agents and Chemotherapy
|
December 9, 2015
International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method
A Espinel-Ingroff, A L Colombo, S Cordoba, et al.
Antimicrobial Agents and Chemotherapy
|
January 15, 2014
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole
A Espinel-Ingroff, M A Pfaller, B Bustamante, et al.
Antimicrobial Agents and Chemotherapy
|
March 7, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine
A Espinel-Ingroff, A Chowdhary, M Cuenca-Estrella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 1, 1997
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
J E Edwards, G P Bodey, R A Bowden, et al.
Antimicrobial Agents and Chemotherapy
|
September 11, 2013
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
A Espinel-Ingroff, M C Arendrup, M A Pfaller, et al.
Page
of 55
Search research articles
Search
Showing results (531-540 of 542) with videos related to
Sort By:
Page
of 55
Antimicrobial Agents and Chemotherapy
|
November 27, 2013
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method
M A Pfaller, A Espinel-Ingroff, B Bustamante, et al.
Diagnostic Microbiology and Infectious Disease
|
May 23, 1998
National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species
M A Pfaller, S A Messer, A Houston, et al.
Journal of Clinical Microbiology
|
August 21, 2009
Wild-type MIC distribution and epidemiological cutoff values for Aspergillus fumigatus and three triazoles as determined by the Clinical and Laboratory Standards Institute broth microdilution methods
M A Pfaller, D J Diekema, M A Ghannoum, et al.
Journal of Clinical Microbiology
|
January 1, 1997
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
A Espinel-Ingroff, M Bartlett, R Bowden, et al.
Journal of Clinical Microbiology
|
March 31, 2012
Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution
M A Pfaller, A Espinel-Ingroff, E Canton, et al.
Antimicrobial Agents and Chemotherapy
|
December 9, 2015
International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method
A Espinel-Ingroff, A L Colombo, S Cordoba, et al.
Antimicrobial Agents and Chemotherapy
|
January 15, 2014
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole
A Espinel-Ingroff, M A Pfaller, B Bustamante, et al.
Antimicrobial Agents and Chemotherapy
|
March 7, 2012
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine
A Espinel-Ingroff, A Chowdhary, M Cuenca-Estrella, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 1, 1997
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
J E Edwards, G P Bodey, R A Bowden, et al.
Antimicrobial Agents and Chemotherapy
|
September 11, 2013
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?
A Espinel-Ingroff, M C Arendrup, M A Pfaller, et al.
Page
of 55